Results

Mesco Pharmaceuticals Ltd. - Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter Ended 31St December, 2018

| Updated on February 05, 2019 Published on February 05, 2019

MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve Notice is hereby given that pursuant to Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, that meeting of the Board of Directors of the Company will be held on Wednesday, 13th February, 2019 to inter-alia consider and approve Unaudited Financial Results pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 for the quarter ended 31st December, 2018.

Pdf Link: Mesco Pharmaceuticals Ltd. - Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter Ended 31St December, 2018

Source : BSE - www.bseindia.com

Published on February 05, 2019
This article is closed for comments.
Please Email the Editor